Clustering analysis for omalizumab responder patient profiles identification. Fenoma study

C. Almonacid Sánchez (Madrid, Spain), J. Soto Campos (Jerez de la Frontera, Cádiz, Spain), P. Campo Mozo (Málaga, Spain), A. Moreira Jorge (Barcelona, Spain), I. Davila Gonzalez (Salamanca, Spain)

Source: International Congress 2018 – Asthma management
Session: Asthma management
Session type: Poster Discussion
Number: 1689
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-posterWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Almonacid Sánchez (Madrid, Spain), J. Soto Campos (Jerez de la Frontera, Cádiz, Spain), P. Campo Mozo (Málaga, Spain), A. Moreira Jorge (Barcelona, Spain), I. Davila Gonzalez (Salamanca, Spain). Clustering analysis for omalizumab responder patient profiles identification. Fenoma study. 1689

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cluster analysis identifies distinct clinical phenotypes with poor treatment responsiveness in asthma.
Source: International Congress 2018 – Asthma: clinical screening tools
Year: 2018


Cluster analysis and clinical asthma phenotypes
Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping
Year: 2013


Assessment of a responder identification treatment algorithm for omalizumab in a naturalistic setting
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


Identification of clinical phenotypes using cluster analyses in COPD patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


Longitudinal validation of clinical COPD phenotypes identified by cluster analysis
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011

A network analysis of clinical characteristics of patients with COPD: partial results.
Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients
Year: 2018

Cluster analysis to identify phenotypes in COPD
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009

Identification of asthma phenotypes using cluster analysis
Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease
Year: 2018

Temporal stability of asthma phenotypes identified by a clustering approach: An ECRHS-SAPALDIA-EGEA study
Source: Annual Congress 2012 - Asthma: from childhood environment to adult phenotypes
Year: 2012

Phenotyping asthmatic outpatients by cluster analysis in a real-world setting
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


A pooling based genome-wide analysis identifies new potential candidate genes for atopy in the echrs study
Source: Annual Congress 2009 - Asthma genetics: from genome wide to single nucleotide polymorphisms
Year: 2009

The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes
Source: ERS Lung Science Conference 2016
Year: 2016




Clinical COPD phenotypes identified by cluster analysis: validation with mortality
Source: Eur Respir J 2012; 40: 495-496
Year: 2012


Use of cluster analysis to define COPD phenotypes
Source: Eur Respir J 2010; 36: 472-474
Year: 2010


Cluster analysis identifying patients with COPD at high-risk of 2-year mortality: preliminary results.
Source: International Congress 2017 – Assessing the functional status of patients with COPD
Year: 2017



Clinical, inflammaory and functional analysis before, during and after treatment with Omalizumabe in patients with difficulty control asthma.
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017

Clustering approach and effects of inhaled therapy on breath-fingerprint of newly diagnosed COPD patients: an e-nose based study
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017




Adult asthma phenotypes identified by a cluster analysis on clinical and biological characteristics
Source: International Congress 2018 – Asthma in children and adults: long-term aspects
Year: 2018



Differential mast cell activation by transcriptomic signature analysis in the U-BIOPRED severe asthma cohort
Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases
Year: 2020


Asthma treatment preference study – a conjoint analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 46s
Year: 2002